Description:
Symbicort 160/4.5 mcg Turbuhaler is a combination inhalation therapy containing Budesonide (160 mcg) and Formoterol Fumarate Dihydrate (4.5 mcg) per actuation. It is used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). This dual-action medication offers both anti-inflammatory and bronchodilatory effects, making breathing easier and reducing the frequency and severity of respiratory symptoms.
Therapeutic Uses:
Long-term management of asthma
Maintenance treatment of COPD, including chronic bronchitis and emphysema
Prevention of asthma exacerbations and improvement of lung function
Mechanism of Action:
Budesonide is an inhaled corticosteroid that reduces inflammation and swelling in the airways, helping to control chronic symptoms and prevent flare-ups.
Formoterol is a long-acting beta-2 agonist (LABA) that relaxes the bronchial muscles, allowing for better airflow and rapid symptom relief.
Dosage Form:
Dry Powder Inhaler (Turbuhaler)
Strength:
Budesonide 160 mcg
Formoterol 4.5 mcg per inhalation
Prescription Status:
Prescription-only medication
Note:
Symbicort Turbuhaler is intended for regular, daily use. It is not a substitute for a rescue inhaler in acute asthma attacks unless specifically prescribed as a reliever-controller. Mouth rinsing after use is recommended to reduce the risk of oral infections. Use only under the guidance of a healthcare professional.
Would you like this description formatted for a product catalog or pharmacy website?
